Aurobindo unit, Evive Biotech ink licensing pact to commercialise CIN treatment product in USNeutropenia is a common side-effect of chemotherapy and is a condition characterised by low levels of neutrophils, a type of white blood ce...
Aurobindo Pharma climbs 2% on new product acquisitionThe company hopes this acquisition will help it to enter the branded oncology market in the US.
Stocks in the news: Adani Gas, RCom, GAIL, IDBI Bank, ONGC and Aurobindo PharmaManwhile, ICICI Bank said it will acquire 9.9% stake in non-banking finance company Kisan Finance